Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Pharma
FDA rejects Elevar, Hengrui's PD-1 combo
Elevar and Hengrui's camrelizumab continues the struggle China-made PD-1s have experienced with the FDA.
Angus Liu
May 17, 2024 10:16am
Advancements in cell & gene therapy manufacturing (Part II)
May 17, 2024 8:58am
Fire breaks out at Novo production hub; none injured
May 16, 2024 11:20am
Teva taps Shields to oversee manufacturing and supply division
May 16, 2024 8:15am
Galapagos bolsters decentralized CAR-T manufacturing
May 15, 2024 5:33pm
Eli Lilly settles with med spa selling fake Mounjaro, Zepbound
May 15, 2024 11:38am